UPDATES IN MEDICINE


Гео и язык канала: Весь мир, Английский
Категория: Медицина


🩺 Empowering Patient Care with Evidence 📊
Latest Medical Research, Guidelines & News for Better Patient Care 🌍
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot

Связанные каналы  |  Похожие каналы

Гео и язык канала
Весь мир, Английский
Категория
Медицина
Статистика
Фильтр публикаций


Which statement is correct about the NICE recommendations and clinical evidence for vadadustat in treating symptomatic anaemia in CKD patients on maintenance dialysis?
Опрос
  •   A. Vadadustat is only recommended if it significantly outperforms ESAs in increasing haemoglobin.
  •   B. It is recommended only for ESA-resistant patients, regardless of cost.
  •   C. Vadadustat is an oral alternative to ESAs and can be used to treat symptomatic anaemia HD pts
  •   D. INNO2VATE trials showed vadadustat was superior to ESAs in reducing cardiovascular events.
  •   E. Vadadustat had significantly higher adverse event rates than ESAs.
27 голосов


🔺 Follow UPDATES IN MEDICINE on Instagram for latest tending medical updates

https://www.instagram.com/updates_in_medicine


vadadustat_for_treating_symptomatic_anaemia_in_adults_having_dialysis.pdf
151.1Кб
🔴 Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease : NICE GUIDELINES
#medicalguidelines

Published:  23 January 2025


@Updates_in_Medicine


Abelacimab vs. Rivaroxaban in Atrial Fibrillation

📄 Key Study Findings:

• Abelacimab significantly reduced bleeding risk compared to rivaroxaban in AF patients.

Bleeding events (per 100 person-years):
• Abelacimab 150 mg: 3.2
• Abelacimab 90 mg: 2.6
• Rivaroxaban: 8.4

Safety: Adverse events were comparable across groups.

• Study published in NEJM Jan 2025.

#medicalresearch

@Updates_in_Medicine


ASRA_Pain_Medicine_consensus_practice_infection_control_guidelines.pdf
1.7Мб
🔴 ASRA Pain Medicine consensus practice infection control guidelines for regional anesthesia and pain medicine

#medicalguidelines

Published: 20th January 2025


@Updates_in_Medicine




WHO comments on United States’ announcement of intent to withdraw

The World Health Organization regrets the announcement that the United States of America intends to withdraw from the Organization
Read more


@Updates_in_Medicine


Which statement reflects the most accurate recommendation based on the AGA guideline on Potassium-Competitive Acid Blockers (P-CABs)? (Full guidelines given above)
Опрос
  •   A) Use P-CABs as first-line therapy for GERD in all patients.
  •   B) Use P-CABs routinely for peptic ulcer prophylaxis.
  •   C) Prefer P-CABs over PPIs for H. pylori eradication.
  •   D) Use P-CABs as first-line for nonerosive reflux disease.
  •   E) Prefer P-CABs for mild erosive oesophagitis
84 голосов


Guideline_on_management_of_pneumonia_and_diarrhoea_in_children_up.pdf
2.8Мб
🔴 WHO Guideline on management of pneumonia and diarrhoea in children up to 10 years of age

#medicalguidelines

Published: Dec 2024


@Updates_in_Medicine




What is the recommended treatment for adults with drug-susceptible pulmonary TB according to the latest ATS/CDC/ERS/IDSA guidelines?
Опрос
  •   A. A 4-month regimen of rifapentine, moxifloxacin, isoniazid, and pyrazinamide (2HPZM/2HPM).
  •   B. The standard 6-month regimen of 2HRZE/4HR is required for all cases.
  •   C. A 15-month regimen is preferred due to higher efficacy.
  •   D. A 6-month BPaL regimen is preferred for drug-susceptible TB.
  •   E. Treatment duration is the same for all forms of TB.
96 голосов


Integrating_Potassium_Competitive_Acid_Blockers_Into_Clinical_Practice.pdf
548.0Кб
🔴 AGA Clinical Practice Update on Integrating Potassium - Competitive Acid Blockers Into Clinical Practice

#medicalguidelines

Published: Nov 2024


@Updates_in_Medicine


🔴 New Drug for Stomach Acid Disorders:
AGA Updates on Potassium-Competitive Acid Blockers (P-CABs)


According to the latest AGA guidelines, potassium-competitive acid blockers (P-CABs) are preferred over PPIs in H. pylori eradication regimens due to their superior and rapid acid suppression, improving eradication rates, especially in resistant strains.

However, PPIs remain the mainstay of treatment for GERD and peptic ulcer disease (PUD), as P-CABs are not recommended as first-line therapy for these conditions. Their use is reserved for select cases like severe GERD or refractory acid-related disorders.

Full Guidelines below 👇


@Updates_in_Medicine






Репост из: NEJM (The New England Journal of Medicine)
🔴 Fracture Prevention with Infrequent Zoledronate in Early Postmenopausal Women

📌 Key Findings:

• Zoledronate at baseline & 5 years reduced morphometric vertebral fractures by 44% (RR 0.56; 95% CI 0.34–0.92; P=0.04).

• Fragility fractures, major osteoporotic fractures, and any fractures were significantly lower with zoledronate compared to placebo.

Conclusions: Zoledronate, administered twice over 10 years, effectively prevents vertebral fractures in early postmenopausal women.

🔗 Full study: https://doi.org/10.1056/NEJMoa2407031

#medicalresearch
@The_NEJM




British Thoracic Society Guideline for pleural disease.pdf
3.5Мб
🔴 British Thoracic Society Guideline for pleural disease


@Updates_in_Medicine


maternal_and_child_nutrition_nutrition_and_weight_management_in.pdf
333.0Кб
🔴 Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years : NICE guideline
#medicalguidelines

Published: 15 January 2025


@Updates_in_Medicine


overweight-and-obesity-management-pdf-66143959958725.pdf
871.9Кб
🔴 Overweight and obesity management: NICE guideline

Published: 14 January 2025
#medicalguidelines


@Updates_in_Medicine

Показано 20 последних публикаций.